Learn More
BACKGROUND It has been hypothesized that depletion of cell membrane n3 polyunsaturated fatty acids (PUFA), particularly docosahexanoic acid (DHA), may be of etiological importance in depression. METHODS We measured the fatty acid composition of phospholipid in cell membranes from red blood cells (RBC) of 15 depressive patients and 15 healthy control(More)
Tardive dyskinesia, an involuntary abnormal movement disorder, is a serious untoward effect of neuroleptic treatment. Certain patient populations likely to be treated with neuroleptics have an increased rate of abnormal movements--or stereotypies (ST)--at baseline that may be difficult to differentiate from neuroleptic-related dyskinesias. The objective of(More)
Partners of survivors of childhood sexual abuse may develop a "trauma contagion" marked by high levels of stress, doubts about to key personal values and assumptions about the world, and a tendency to be drawn into unconscious reenactments with the survivor of the abusive relationship. Various treatment interventions are discussed, especially conjoint work(More)
The present study compared baseline assessments of 30 autistic children studied at ages 2.8 to 6.3 years (mean = 4.5; median = 4.5) with assessments at followup 0.38 to 14.3 years later (mean = 5.05; median = 4.33). The assessments included diagnosis, Severity of illness, and intellectual functioning. At the time of followup, when they participated in the(More)
This research measured naltrexone levels in plasma, to assess the relationship between behavioral response to naltrexone and plasma levels, and the effects of naltrexone on weight in hospitalized autistic children (n = 41). A double-blind, placebo-controlled, parallel groups design with fixed dose was used, with random assignment to naltrexone or placebo.(More)
The long-term effects of haloperidol on weight were assessed in 30 children, 25 males and 5 females, diagnosed with autistic disorder whose ages ranged from 3.08 to 8.42 years. They received haloperidol (0.25-3.50 mg/day; mean 1.26 +/- 0.84) for 6 months followed by a 4-week drug withdrawal period. Weights obtained on the last day of the 6-month haloperidol(More)
  • 1